Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Champions Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Champions Oncology Enters into Agreement with NSABP Foundation and Puma Biotechnology 11
Champions Oncology Enters into Agreement with AstraZeneca 12
Champions Oncology Enters into Agreement with Addario 13
Addario Lung Cancer Medical Institute, Champions Oncology and ROS1ders Enter into Agreement 14
Champions Oncology Enters into Co-Development Agreement 15
Insilico Medicine Enters into Research Agreement with Champions Oncology 16
Champions Enters Into Drug Discovery And Development Agreement With Teva 17
Licensing Agreements 18
Champions Oncology Enters into Licensing Agreement with Pfizer 18
Equity Offering 19
Champions Oncology Raises USD5 Million in Public Offering of Shares 19
Champions Oncology Raises USD14 Million in Private Placement of Units 21
Champions Oncology Completes Private Placement Of Shares For US$9 Million 23
Champions Oncology Inc – Key Competitors 24
Champions Oncology Inc – Key Employees 25
Champions Oncology Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Strategy And Business Planning 27
Mar 16, 2017: Champions Oncology Announces Plan to Open New Lab Facility in Rockville, Maryland 27
Financial Announcements 28
Sep 13, 2018: Champions Oncology reports record quarterly revenue of $6.2 million 28
Jul 26, 2018: Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018 29
Mar 15, 2018: Champions Oncology Reports Quarterly Revenue of $5.1 Million 31
Dec 07, 2017: Champions Oncology Reports Record Quarterly Revenue of $5.2M 33
Sep 14, 2017: Champions Oncology Reports Record Quarterly Revenue of $5 Million 35
Jul 27, 2017: Champions Oncology Reports 38% Revenue Growth for Fiscal Year Ended April 30, 2017 37
Mar 16, 2017: Champions Oncology Reports 40% Revenue Growth 39
Government and Public Interest 41
Sep 26, 2017: Champions Oncology announces $2 million award from the National Cancer Institute to develop and evaluate prostate cancer PDX models 41
Product News 42
Sep 18, 2017: Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft model responses and patient responses to oncology therapies 42
Feb 16, 2017: Champions Oncology Announces New Collection of Patient-Derived Xenograft Models Available for Translational Research 43
Other Significant Developments 44
Feb 21, 2018: Motivated Patients with ROS1 Cancer Initiate Global Research Study 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
Champions Oncology Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Champions Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Champions Oncology Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Champions Oncology Enters into Agreement with NSABP Foundation and Puma Biotechnology 11
Champions Oncology Enters into Agreement with AstraZeneca 12
Champions Oncology Enters into Agreement with Addario 13
Addario Lung Cancer Medical Institute, Champions Oncology and ROS1ders Enter into Agreement 14
Champions Oncology Enters into Co-Development Agreement 15
Insilico Medicine Enters into Research Agreement with Champions Oncology 16
Champions Enters Into Drug Discovery And Development Agreement With Teva 17
Champions Oncology Enters into Licensing Agreement with Pfizer 18
Champions Oncology Raises USD5 Million in Public Offering of Shares 19
Champions Oncology Raises USD14 Million in Private Placement of Units 21
Champions Oncology Completes Private Placement Of Shares For US$9 Million 23
Champions Oncology Inc, Key Competitors 24
Champions Oncology Inc, Key Employees 25
Champions Oncology Inc, Other Locations 26
Champions Oncology Inc, Subsidiaries 26
List of Figures
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Champions Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9